Editas Medicine Inc (NASDAQ:EDIT)

34.64
Delayed Data
As of Apr 16
 -6.34 / -15.47%
Today’s Change
21.41
Today|||52-Week Range
99.95
-50.59%
Year-to-Date
Nasdaq Stays Flat as Workhorse Drives Higher, Editas Sinks
Apr 16 / MotleyFool.com - Paid Partner Content
Spring Cleaning for Investors
Apr 08 / MotleyFool.com - Paid Partner Content
Why Editas Medicine Stock Is Getting Crushed Today
Apr 16 / MotleyFool.com - Paid Partner Content
An End to This Rare Syndrome Could Be an Opportunity for Investors
Apr 07 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks Ripe for Spring Portfolio Cleaning
Apr 16 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close40.98
Today’s open38.20
Day’s range33.59 - 39.16
Volume237,430
Average volume (3 months)2,815,880
Market cap$2.3B
Data as of 4:51pm ET, 04/16/2021

Growth & Valuation

Earnings growth (last year)+26.05%
Earnings growth (this year)-66.43%
Earnings growth (next 5 years)-2.31%
Revenue growth (last year)+341.93%
P/E ratioNM
Price/Sales45.29
Price/Book5.51

Competitors

 Today’s
change
Today’s
% change
RCUSArcus Biosciences In...-1.86-5.32%
XNCRXencor Inc-2.47-5.53%
DRNADicerna Pharmaceutic...+0.38+1.33%
----
Data as of 4:00pm ET, 04/16/2021

Financials

Next reporting dateMay 17, 2021
EPS forecast (this quarter)-$0.76
Annual revenue (last year)$90.7M
Annual profit (last year)-$116.0M
Net profit margin-127.82%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts